FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066570 [Registered on: 30/04/2024] Trial Registered Prospectively
Last Modified On: 25/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   An Interventional study with LM Potency on patients with grade 1 Hypertension  
Scientific Title of Study   Efficacy Of Homoeopathic Medicines Using LM Potency in Management Of Essential Hypertension(Grade 1) in Patients having Body Mass Index 25-35 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrArfana Chauhan 
Designation  PG scholar 
Affiliation  Smt A J Savla Homoepathic Medical college and Research Institute 
Address  Room no 10 Department of Medicine Ground floor Smt A J Savla Homoeopathic Medical college and Research Institute Pushapnjali Building Near district session court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  7041637799  
Fax    
Email  chauhan.arfana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrAnand Desai 
Designation  Professor PG Department of Organon of Medicine and Homoeopathic philosophy 
Affiliation  Smt A J Savla Homoepathic Medical college and Research Institute 
Address  Room no 10 Department of Medicine ground floor Smt A J Savla Homoeopathic Medical college and Research Institute Pushapnjali Building Near district session court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  9979885148  
Fax    
Email  dranandjvb@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrArfana Chauhan 
Designation  PG scholar 
Affiliation  Smt A J Savla Homoepathic Medical college and Research Institute 
Address  Room no 10 Department of Medicine Ground floor Smt A J Savla Homoeopathic Medical college and Research Institute Pushapnjali Building Near district session court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  7041637799  
Fax    
Email  chauhan.arfana@gmail.com  
 
Source of Monetary or Material Support  
Smt A J Savla Homoeopathic Medical college and Research Institute Pushpanjali Building Near District Session Court Mehsana Gujarat 384001  
 
Primary Sponsor  
Name  DrArfana Chauhan 
Address  Room no 10 Department of Medicine Ground floor Smt A J Savla Homoeopathic Medical college and Research Institute Pushpanjali Building Near District Session Court Mehsana Gujarat 384001  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrArfana Chauhan  Smt A J Savla Homoeopathic Medical college and Research Institute   Room No 10 Department Of Medicine Ground Floor Pushpanjali Building Near District Session Court Mehsana
Mahesana
GUJARAT 
7041637799

chauhan.arfana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Smt A J Savla Homoeopathic medical college institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Medicine In LM potency  Potency LM Potency Dose as per the criteria of LM Potency Medicine will dispensed as per the criteria of LM potency Frequency as per need of case route of administration oral route Duration of therapy up to 8 months as per need of case  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  79.00 Year(s)
Gender  Both 
Details  Participants must have a confirmed diagnosis of essential hypertension as per established medical criteria
Participants with baseline Systolic Blood Pressure
more than 120 to 159 and Diastolic Blood Pressure more than 80 to 99 who are not on any anti hypertensive medicines
Participants with a body mass index of 25 to 35
Participants willing to provide informed consent to participate in the study and also who can fill up the Questionnaire 
 
ExclusionCriteria 
Details  Patients who are suffering from secondary Hypertension of known aetiology such as renal disease pheochromocytoma or Cushing’s syndrome known diabetics, history of myocardial infarction severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases any systemic illness consumptive disease autoimmune disease cancer hepatic disease renal disease
Patients receiving any drugs known to affect Blood Pressure or medical treatments that can influence the Blood Pressure having a history of alcohol or drug abuse
Women who are taking contraceptive pills pregnancy and lactating mother
Patients having class 2 and class 3 obesity 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
changes in the blood pressure both systolic and diastolic   data will be assessed from baseline 2 4 6 8 months and changes in the blood pressure will be assessed 
 
Secondary Outcome  
Outcome  TimePoints 
changes in the Minichal Questinnorie score   from baseline to at the end of treatment 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/05/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a prospective pre test post test interventional trial to assess the efficacy of Homoeopathic medicines in LM potency in 40 participants of grade 1 hypertension BMI 25-35 as per the inclusion criteria and exclusion criteria from OPD The Primary outcome will assess the changes in Blood pressure after giving Individual Homoeopathic medicines in LM potency  at 2 4 6 8  months.
Secondary outcome will assess changes in MINICHAL Questionnarie after giving Individual Homoeopathic medicines in LM potency from baseline and at the end of treatment .
 
Close